New Directions in Therapeutic Angiogenesis and Arteriogenesis in Peripheral Arterial Disease.

Circulation Research
Brian H Annex, John P Cooke

Abstract

The prevalence of peripheral arterial disease (PAD) in the United States exceeds 10 million people, and PAD is a significant cause of morbidity and mortality across the globe. PAD is typically caused by atherosclerotic obstructions in the large arteries to the leg(s). The most common clinical consequences of PAD include pain on walking (claudication), impaired functional capacity, pain at rest, and loss of tissue integrity in the distal limbs that may lead to lower extremity amputation. Patients with PAD also have higher than expected rates of myocardial infarction, stroke, and cardiovascular death. Despite advances in surgical and endovascular procedures, revascularization procedures may be suboptimal in relieving symptoms, and some patients with PAD cannot be treated because of comorbid conditions. In some cases, relieving obstructive disease in the large conduit arteries does not assure complete limb salvage because of severe microvascular disease. Despite several decades of investigational efforts, medical therapies to improve perfusion to the distal limb are of limited benefit. Whereas recent studies of anticoagulant (eg, rivaroxaban) and intensive lipid lowering (such as PCSK9 [proprotein convertase subtilisin/kexin type ...Continue Reading

References

Jun 17, 1998·The Journal of Clinical Investigation·T MuroharaJ M Isner
Jan 30, 1999·Journal of Molecular and Cellular Cardiology·C WolfJ Schaper
Oct 22, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Wei-Jun CaiJutta Schaper
Nov 5, 2002·Nature Medicine·Edward J RebarFrank J Giordano
Jan 25, 2003·Annals of the New York Academy of Sciences·Aernout LuttunPeter Carmeliet
Jun 14, 2003·Circulation Research·Jean-Sébastien SilvestreBernard I Lévy
Jun 15, 2004·Journal of the American College of Cardiology·Jalees RehmanKeith L March
Jul 6, 2004·Nature Medicine·Daniel J CeradiniGeoffrey C Gurtner
Aug 3, 2005·The Journal of Clinical Investigation·Eric AckahWilliam C Sessa
Dec 13, 2005·Experimental Cell Research·Masabumi Shibuya, Lena Claesson-Welsh
Feb 9, 2006·Cellular and Molecular Life Sciences : CMLS·S Cébe-SuarezK Ballmer-Hofer
Mar 28, 2006·Journal of Cellular and Molecular Medicine·M HeilW Schaper
Apr 25, 2006·Nature Reviews. Molecular Cell Biology·Anna-Karin OlssonLena Claesson-Welsh
Mar 27, 2007·American Journal of Preventive Medicine·Matthew A AllisonMichael H Criqui
May 25, 2007·Nature Reviews. Molecular Cell Biology·Ralf H Adams, Kari Alitalo
Apr 4, 2008·Investigative Ophthalmology & Visual Science·Katsuji KiuchiPeter A Campochiaro
Jun 3, 2008·Blood·Karolien CastermansArjan W Griffioen
Jun 14, 2008·Cardiovascular Research·Carmen UrbichStefanie Dimmeler
Oct 17, 2008·Nature Reviews. Cancer·Steven J Harper, David O Bates
Jul 28, 2009·Journal of Thrombosis and Haemostasis : JTH·M C Yoder
Aug 6, 2009·Science Signaling·Michael SchleicherWilliam C Sessa
Feb 20, 2010·Arteriosclerosis, Thrombosis, and Vascular Biology·Ngan F HuangJohn P Cooke

❮ Previous
Next ❯

Citations

Jun 11, 2021·Circulation Research·Nicholas J Leeper, Naomi M Hamburg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Expert Review of Cardiovascular Therapy
Fadi ShamounGeorge Abela
The Cochrane Database of Systematic Reviews
Alina Andras, Bart Ferket
VASA. Zeitschrift für Gefässkrankheiten
C DiehmH Lawall
© 2021 Meta ULC. All rights reserved